106 related articles for article (PubMed ID: 38821091)
1. Stereotactic ablative radiotherapy for primary kidney cancer - Authors' reply.
Siva S; Moon D; Pryor D
Lancet Oncol; 2024 Jun; 25(6):e230. PubMed ID: 38821091
[No Abstract] [Full Text] [Related]
2. Stereotactic ablative radiotherapy for primary kidney cancer.
Brown N; Breen DJ; Buckley BT; Clements W; Gangi A; Rogan C
Lancet Oncol; 2024 Jun; 25(6):e229. PubMed ID: 38821090
[No Abstract] [Full Text] [Related]
3. Stereotactic ablative radiotherapy for primary kidney cancer.
Bhargava P; Jena R; Giri RK
Lancet Oncol; 2024 Jun; 25(6):e228. PubMed ID: 38821089
[No Abstract] [Full Text] [Related]
4. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.
Siva S; Kothari G; Muacevic A; Louie AV; Slotman BJ; Teh BS; Lo SS
Nat Rev Urol; 2017 Sep; 14(9):549-563. PubMed ID: 28631740
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Ablative Body Radiotherapy: An Emerging Weapon in the Treatment Armamentarium for Renal Cell Carcinoma or a Potential Avenue for Overtreatment?
Magee DE; Wong JK; Correa AF
Eur Urol; 2022 Dec; 82(6):623-624. PubMed ID: 35945083
[No Abstract] [Full Text] [Related]
6. Re: Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer.
Bourillon A; Bensalah K
Eur Urol; 2024 Jul; 86(1):76. PubMed ID: 38538423
[No Abstract] [Full Text] [Related]
7. The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma.
Ali M; Mooi J; Lawrentschuk N; McKay RR; Hannan R; Lo SS; Hall WA; Siva S
Eur Urol; 2022 Dec; 82(6):613-622. PubMed ID: 35843777
[TBL] [Abstract][Full Text] [Related]
8. [Stereotactic body radiation therapy for primary kidney cancer].
Abancourt L; Le Guévelou J; Taillez A; Vu A; de Crevoisier R; Supiot S; Hennequin C; Chapet O; Blanchard P; Mirabel X; Lartigau É; Pasquier D
Cancer Radiother; 2023 Sep; 27(6-7):568-572. PubMed ID: 37543493
[TBL] [Abstract][Full Text] [Related]
9. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
Miccio JA; Oladeru OT; Jun Ma S; Johung KL
Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
[TBL] [Abstract][Full Text] [Related]
10. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
Miccio J; Johung K
Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
[TBL] [Abstract][Full Text] [Related]
11. The investigational role of cytoreductive stereotactic ablative radiation therapy (SABR) to the primary tumor in metastatic kidney cancer.
Ingrosso G; Lancia A; Festa E; Pisani AR; Bellavita R; Aristei C; Detti B
Expert Rev Anticancer Ther; 2024 Jul; 24(7):477-479. PubMed ID: 38682638
[No Abstract] [Full Text] [Related]
12. [German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist].
Müller AC; van Oorschot B; Micke O; Guckenberger M
Strahlenther Onkol; 2018 Jan; 194(1):1-8. PubMed ID: 28819766
[TBL] [Abstract][Full Text] [Related]
13. A review of stereotactic ablative radiotherapy for nonmetastatic renal cell carcinoma.
Zalay O; Mehra P; Pereira I; Malone J; Malone S
World J Urol; 2024 Jan; 42(1):52. PubMed ID: 38244135
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
Zaorsky NG; Lehrer EJ; Kothari G; Louie AV; Siva S
Eur Urol Oncol; 2019 Sep; 2(5):515-523. PubMed ID: 31302061
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
Correa RJM; Louie AV; Staehler M; Warner A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh BS; Lo SS; Muacevic A; Siva S
J Urol; 2019 Jun; 201(6):1097-1104. PubMed ID: 30741849
[TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
Eur Urol Focus; 2019 Nov; 5(6):958-969. PubMed ID: 31248849
[TBL] [Abstract][Full Text] [Related]
17. [A systematic review of radiotherapy for primary renal cell carcinoma].
Gladilina IA; Shabanov MA; Kushlinskii NE; Bliganov PI; Sergeev AN
Urologiia; 2022 Mar; (1):96-101. PubMed ID: 35274868
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma.
Kaidar-Person O; Price A; Schreiber E; Zagar TM; Chen RC
Clin Genitourin Cancer; 2017 Oct; 15(5):e851-e854. PubMed ID: 28462856
[No Abstract] [Full Text] [Related]
19. Renal-cell carcinoma.
Doh L; Curtis AE; Teh BS
N Engl J Med; 2006 Mar; 354(10):1095-6; author reply 1095-6. PubMed ID: 16525153
[No Abstract] [Full Text] [Related]
20. The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease.
Marandino L; Ciccarese C; Francolini G; Amparore D; Campi R;
Minerva Urol Nephrol; 2023 Apr; 75(2):260-264. PubMed ID: 36999845
[No Abstract] [Full Text] [Related]
[Next] [New Search]